Catalyst Biosciences, Inc. (CBIO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$11.81
Day's range
$12.3

Crescent Biopharma Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 4.13 M $75.93 M   0.00% 13.60%
BVF INC/IL 05/15/2026 2.75 M $50.49 M   0.00% 9.04%
FAIRMOUNT FUNDS MANAGEMENT LLC 05/15/2026 2.75 M $50.48 M   0.00% 9.04%
VR ADVISER, LLC 05/15/2026 2.13 M $39.19 M   0.00% 7.02%
FCPM III SERVICES B.V. 05/15/2026 1.68 M $30.82 M   0.00% 5.52%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 1.51 M $27.74 M   1,251.68% 4.97%
VESTAL POINT CAPITAL, LP 05/15/2026 1.50 M $27.56 M   0.00% 4.93%
OPALEYE MANAGEMENT INC. 05/15/2026 1.31 M $24.11 M   11.40% 4.32%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 1.16 M $21.31 M   32.97% 3.82%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 801.40 K $14.72 M   100.00% 2.64%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 482.50 K $8.86 M   -19.58% 1.59%
DEEP TRACK CAPITAL, LP 05/15/2026 453.69 K $8.33 M   0.00% 1.49%
RTW INVESTMENTS, LP 05/15/2026 372.86 K $6.85 M   0.00% 1.23%
NEXTBIO CAPITAL MANAGEMENT LP 05/14/2026 372.86 K $6.85 M   0.00% 1.23%
MILLENNIUM MANAGEMENT LLC 05/15/2026 323.55 K $5.94 M   422.85% 1.06%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 303.55 K $5.58 M   -10.23% 1.00%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 300.00 K $5.51 M   0.00% 0.99%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 264.00 K $4.85 M   0.00% 0.87%
GOLDMAN SACHS GROUP INC 05/15/2026 228.48 K $4.20 M   805.03% 0.75%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 213.64 K $3.92 M   274.48% 0.70%
PERCEPTIVE ADVISORS LLC 05/29/2026 206.94 K $3.80 M   -54.39% 0.68%
MARSHALL WACE, LLP 05/15/2026 200.78 K $3.69 M   819.91% 0.66%
EXOME ASSET MANAGEMENT LLC 05/15/2026 153.19 K $2.81 M   100.00% 0.50%
JENNISON ASSOCIATES LLC 05/06/2026 152.97 K $2.81 M   100.00% 0.50%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 130.50 K $2.40 M   100.00% 0.43%
TWO SIGMA INVESTMENTS, LP 05/15/2026 115.83 K $2.13 M   -7.50% 0.38%
BLACKROCK, INC. 05/13/2026 115.73 K $2.13 M   5.95% 0.38%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 104.22 K $1.92 M   14.43% 0.34%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 88.87 K $1.63 M   100.00% 0.29%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 85.00 K $1.56 M   -3.06% 0.28%
UBS GROUP AG 05/05/2026 82.71 K $1.52 M   1,060.79% 0.27%
WOODLINE PARTNERS LP 05/15/2026 74.00 K $1.36 M   0.00% 0.24%
BURKEHILL GLOBAL MANAGEMENT, LP 05/15/2026 74.00 K $1.36 M   0.00% 0.24%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 50.27 K $923.52 K   -91.70% 0.17%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 49.42 K $907.90 K   100.00% 0.16%
JPMORGAN CHASE & CO 05/13/2026 41.00 K $681.49 K   75.69% 0.13%
STATE STREET CORP 05/15/2026 39.07 K $717.66 K   49.01% 0.13%
BARCLAYS PLC 05/15/2026 30.19 K $554.57 K   100.00% 0.10%
BANK OF AMERICA CORP /DE/ 05/18/2026 29.28 K $537.82 K   425.34% 0.10%
MOORE CAPITAL MANAGEMENT, LP 05/15/2026 25.00 K $459.25 K   0.00% 0.08%
LIGHTHOUSE INVESTMENT PARTNERS, LLC 05/14/2026 25.00 K $459.25 K   100.00% 0.08%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2026 24.90 K $457.47 K   0.00% 0.08%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 24.26 K $445.69 K   -48.05% 0.08%
CITIGROUP INC 05/11/2026 20.17 K $370.51 K   3,137.40% 0.07%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 19.53 K $358.77 K   100.00% 0.06%
MORGAN STANLEY 05/15/2026 18.58 K $341.26 K   -32.50% 0.06%
OMERS ADMINISTRATION CORP 05/15/2026 17.80 K $326.99 K   53.45% 0.06%
NORTHERN TRUST CORP 05/14/2026 17.23 K $316.50 K   0.00% 0.06%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 15.69 K $288.30 K   337.77% 0.05%
VERDAD ADVISERS, LP 05/15/2026 12.75 K $234.18 K   100.00% 0.04%

Crescent Biopharma Inc. institutional Ownership - FAQ's

During the previous two years, 25 institutional investors and hedge funds held shares of Crescent Biopharma Inc.. The most heavily invested institutionals were:

RENAISSANCE TECHNOLOGIES LLC: 0

Alyeska Investment Group, L.P.: 0

SUSQUEHANNA INTERNATIONAL GROUP, LLP: 0

Verdad Advisers, LP: 0

Deep Track Capital, LP: 0

Lighthouse Investment Partners, LLC: 0

24.12% of Crescent Biopharma Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 897.00 K shares in the last 24 months. This purchase volume represents approximately $10.78 M in transactions.